N02CD Calcitonin gene-related peptide (CGRP) antagonists
ATC group of level 4 – chemical subgroup · in plain English: medicines for migraine
This site has the patient leaflet or the SPC of 10 medicines in this group and its subgroups.
- 10 prescription only (POM)
Place in the ATC classification
- N Nervous system drugs 4,479 medicines
- N02 Analgesics 1,032 medicines
- N02C Antimigraine preparations 108 medicines
-
N02CD Calcitonin gene-related peptide (CGRP) antagonists 10 medicines
- N02CD01 erenumab 4 medicines
- N02CD02 galcanezumab 3 medicines
- N02CD03 fremanezumab 2 medicines
-
N02CD Calcitonin gene-related peptide (CGRP) antagonists 10 medicines
- N02C Antimigraine preparations 108 medicines
- N02 Analgesics 1,032 medicines
Active substances in the group
- Eptinezumab 1 medicine
- Erenumab 4 medicines
- Fremanezumab 2 medicines
- Galcanezumab 3 medicines
Medicines in the group and its subgroups
Other groups of the same level
- N02CA Ergot alkaloids, antimigraine 1 medicine
- N02CC Selective serotonin (5HT1) agonists, antimigraine drugs 85 medicines
- N02CX Other antimigraine preparations 12 medicines
Other names of the ATC group
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group N02CD
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
